Balchem vs Quaker Chemical
Quaker Chemical reported revenue of $1.9 billion in fiscal 2025, 1.8 times Balchem's $1.0 billion in fiscal 2025. Balchem's revenue grew 8.8% in its latest year, and Quaker Chemical's grew 2.7%. Balchem had an operating margin of 20.2%, against 2.8% at Quaker Chemical. Free cash flow was $173 million at Balchem and $81 million at Quaker Chemical.
Side by side
| Balchem | Quaker Chemical | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $1.0B | $1.9B |
| Revenue growth | 8.8% | 2.7% |
| Revenue growth a year, last 5 years | 8.1% | 5.9% |
| Gross margin | 35.7% | 36.0% |
| Operating margin | 20.2% | 2.8% |
| Net margin | 14.9% | −0.1% |
| Free cash flow | $173M | $81M |
| Free cash flow margin | 16.7% | 4.3% |
| Return on capital | — | 1.3% |
| Net debt to EBITDA | — | 6.1x |
| Dividends and buybacks | $136M | $76M |
| Change in diluted share count | −0.3% | −2.2% |
| Last close | $170.62 | $154.87 |
| P/E at the last close | 32.1× | 27.6× |
| Insider trades, last 12 months | sold $2.3 million | sold $207,544 |
| Piotroski F-score | — | 5 of 9 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
BalchemQuaker Chemical
Operating margin
Percent of revenue
BalchemQuaker Chemical
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
BalchemQuaker Chemical
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Balchem and Quaker Chemical pages.